Cite
Targeting the Complement Alternative Pathway Permits Graft Versus Leukemia Activity while Preventing Graft Versus Host Disease.
MLA
Nguyen, Hung, et al. “Targeting the Complement Alternative Pathway Permits Graft Versus Leukemia Activity While Preventing Graft Versus Host Disease.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 26, no. 13, July 2020, pp. 3481–90. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-19-1717.
APA
Nguyen, H., Alawieh, A., Bastian, D., Kuril, S., Dai, M., Daenthanasanmak, A., Zhang, M., Iamsawat, S., Schutt, S. D., Wu, Y., Sleiman, M. M., Shetty, A., Atkinson, C., Sun, S., Varela, J. C., Tomlinson, S., & Yu, X.-Z. (2020). Targeting the Complement Alternative Pathway Permits Graft Versus Leukemia Activity while Preventing Graft Versus Host Disease. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 26(13), 3481–3490. https://doi.org/10.1158/1078-0432.CCR-19-1717
Chicago
Nguyen, Hung, Ali Alawieh, David Bastian, Sandeepkumar Kuril, Min Dai, Anusara Daenthanasanmak, Mengmeng Zhang, et al. 2020. “Targeting the Complement Alternative Pathway Permits Graft Versus Leukemia Activity While Preventing Graft Versus Host Disease.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 26 (13): 3481–90. doi:10.1158/1078-0432.CCR-19-1717.